IGY Immune Technologies & Life Sciences (ITLS) acquired technology to isolate and purify egg based antibodies in purities from 10% to 95% pure.
Read MoreTerry Dyck
Sharad Mistry
David Mason
John Mason – Researcher & Development
John Henderson – Marketing
Ameann DeJohn – Ameann Solutions
Ian Cooke – Facilities Engineer
Dr. Anthony Iacopino – Dean, Faculty of Dentistry
Roger Upton – Ironwood Clay
Dr. Wensheng Qui – Lakehead University Biology
Dr. John Webb
Dr. Frank Mauro
Dr. Sheetal Sapra
Dr. Keith Ly
Dr. Jeanette Jackson
Terry Dyck – Chairman
Dr. Brian Scott – Dentist
Rashid Bux – CEO Biomark
IGY Immune Technologies & Life Sciences (ITLS) acquired technology to isolate and purify egg based antibodies in purities from 10% to 95% pure.
Read MoreIgY Life Sciences announces the launch of the companies updated website. The website is prepared for the purpose of educating the public about the importance of IgY and what purpose it is used for.
Read More